1. Home
  2. SRRK vs TENB Comparison

SRRK vs TENB Comparison

Compare SRRK & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • TENB
  • Stock Information
  • Founded
  • SRRK 2012
  • TENB 2002
  • Country
  • SRRK United States
  • TENB United States
  • Employees
  • SRRK N/A
  • TENB N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • TENB Computer Software: Prepackaged Software
  • Sector
  • SRRK Health Care
  • TENB Technology
  • Exchange
  • SRRK Nasdaq
  • TENB Nasdaq
  • Market Cap
  • SRRK 4.2B
  • TENB 4.9B
  • IPO Year
  • SRRK 2018
  • TENB 2018
  • Fundamental
  • Price
  • SRRK $43.12
  • TENB $40.83
  • Analyst Decision
  • SRRK Strong Buy
  • TENB Buy
  • Analyst Count
  • SRRK 7
  • TENB 17
  • Target Price
  • SRRK $40.43
  • TENB $50.06
  • AVG Volume (30 Days)
  • SRRK 1.1M
  • TENB 947.3K
  • Earning Date
  • SRRK 11-12-2024
  • TENB 02-04-2025
  • Dividend Yield
  • SRRK N/A
  • TENB N/A
  • EPS Growth
  • SRRK N/A
  • TENB N/A
  • EPS
  • SRRK N/A
  • TENB N/A
  • Revenue
  • SRRK N/A
  • TENB $877,596,000.00
  • Revenue This Year
  • SRRK N/A
  • TENB $14.43
  • Revenue Next Year
  • SRRK N/A
  • TENB $9.64
  • P/E Ratio
  • SRRK N/A
  • TENB N/A
  • Revenue Growth
  • SRRK N/A
  • TENB 13.97
  • 52 Week Low
  • SRRK $6.76
  • TENB $35.25
  • 52 Week High
  • SRRK $46.19
  • TENB $53.50
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 57.37
  • TENB 51.98
  • Support Level
  • SRRK $38.72
  • TENB $37.78
  • Resistance Level
  • SRRK $45.15
  • TENB $40.70
  • Average True Range (ATR)
  • SRRK 2.33
  • TENB 1.24
  • MACD
  • SRRK -0.32
  • TENB 0.27
  • Stochastic Oscillator
  • SRRK 73.28
  • TENB 54.76

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: